Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wehling

Showing results (101-110 of 208) with videos related to

Pageof 21
Sort By:
European Journal of Pharmacology|July 8, 1998
Are high-affinity progesterone binding site(s) from porcine liver microsomes members of the sigma receptor family?C Meyer, K Schmieding, E Falkenstein, et al.
Platelets|February 4, 2010
The PFA-100R cannot detect blood group-dependent inhibition of platelet function by eptifibatide or abciximab at therapeutic plasma concentrationsM Feuring, A Ruf, A Schultz, et al.
Klinische Wochenschrift|January 19, 1990
Effects of aldosterone on intralymphocytic sodium and potassium in patients with essential hypertensionM Wehling, S Kuhls, U Kuhnle, et al.
Clinical Endocrinology|November 1, 1989
Inheritance of mineralocorticoid effector abnormalities of human mononuclear leucocytes in families with pseudohypoaldosteronismM Wehling, U Kuhnle, C Daumer, et al.
Medizinische Klinik (Munich, Germany : 1983)|February 20, 1999
[Conversion from oral ACE inhibitor to intravenous quinaprilat administration in mild to moderate essential hypertension]B M Schmidt, J Smilde, C Oldenbroek, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|December 14, 1999
Rapid aldosterone effects on tyrosine phosphorylation in vascular smooth muscle cellsJ C Manegold, E Falkenstein, M Wehling, et al.
MMW Fortschritte Der Medizin|February 5, 2002
[Drug therapy in the old age. Drug effects in the elderly]C U Vogel, A Peiter, M Feuring, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 31, 2001
Does intention-to-treat analysis answer all questions in long-term mortality trials? Considerations on the basis of the ANZ trialH C Tillmann, N Sharpe, G Sponer, et al.
Der Internist|July 27, 1999
[Beta-blockers. Value in cardiovascular diseases]M Feuring, B M Schmidt, M Christ, et al.
The American Journal of Physiology|April 1, 1987
Effect of aldosterone on sodium and potassium concentrations in human mononuclear leukocytesM Wehling, D Armanini, T Strasser, et al.
Pageof 21

Showing results (101-110 of 208) with videos related to

Sort By:
Pageof 21
European Journal of Pharmacology|July 8, 1998
Are high-affinity progesterone binding site(s) from porcine liver microsomes members of the sigma receptor family?C Meyer, K Schmieding, E Falkenstein, et al.
Platelets|February 4, 2010
The PFA-100R cannot detect blood group-dependent inhibition of platelet function by eptifibatide or abciximab at therapeutic plasma concentrationsM Feuring, A Ruf, A Schultz, et al.
Klinische Wochenschrift|January 19, 1990
Effects of aldosterone on intralymphocytic sodium and potassium in patients with essential hypertensionM Wehling, S Kuhls, U Kuhnle, et al.
Clinical Endocrinology|November 1, 1989
Inheritance of mineralocorticoid effector abnormalities of human mononuclear leucocytes in families with pseudohypoaldosteronismM Wehling, U Kuhnle, C Daumer, et al.
Medizinische Klinik (Munich, Germany : 1983)|February 20, 1999
[Conversion from oral ACE inhibitor to intravenous quinaprilat administration in mild to moderate essential hypertension]B M Schmidt, J Smilde, C Oldenbroek, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|December 14, 1999
Rapid aldosterone effects on tyrosine phosphorylation in vascular smooth muscle cellsJ C Manegold, E Falkenstein, M Wehling, et al.
MMW Fortschritte Der Medizin|February 5, 2002
[Drug therapy in the old age. Drug effects in the elderly]C U Vogel, A Peiter, M Feuring, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 31, 2001
Does intention-to-treat analysis answer all questions in long-term mortality trials? Considerations on the basis of the ANZ trialH C Tillmann, N Sharpe, G Sponer, et al.
Der Internist|July 27, 1999
[Beta-blockers. Value in cardiovascular diseases]M Feuring, B M Schmidt, M Christ, et al.
The American Journal of Physiology|April 1, 1987
Effect of aldosterone on sodium and potassium concentrations in human mononuclear leukocytesM Wehling, D Armanini, T Strasser, et al.
Pageof 21